These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 38852942

  • 1. Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019.
    Girardi M, Carlson K, Huang X, Corman SL, Edmundson P, Schmier J, Kale HP, Raina R, Foss F.
    J Dermatolog Treat; 2024 Dec; 35(1):2360568. PubMed ID: 38852942
    [Abstract] [Full Text] [Related]

  • 2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [Abstract] [Full Text] [Related]

  • 3. Extracorporeal photopheresis and multimodality therapy in patients with T-cell cutaneous lymphomas: Real-life experience in Argentina.
    Baquero Rey JA, Zambrano Franco EA, Andrade Miranda A, Marciano S, Mazzuoccolo LD, Enz PA.
    J Clin Apher; 2021 Dec; 36(6):815-822. PubMed ID: 34478581
    [Abstract] [Full Text] [Related]

  • 4. What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
    Akilov OE.
    Cells; 2023 Sep 20; 12(18):. PubMed ID: 37759543
    [Abstract] [Full Text] [Related]

  • 5. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2006 Sep 20; 6(6):1-82. PubMed ID: 23074497
    [Abstract] [Full Text] [Related]

  • 6. Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome.
    McGirt LY, Thoburn C, Hess A, Vonderheid EC.
    Photodermatol Photoimmunol Photomed; 2010 Aug 20; 26(4):182-91. PubMed ID: 20626820
    [Abstract] [Full Text] [Related]

  • 7. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
    Ling YL, Huang X, Mitri G, Lovelace B, Pham A, Knobler R, Li X, Gao X.
    J Dermatolog Treat; 2020 Feb 20; 31(1):91-98. PubMed ID: 30892982
    [Abstract] [Full Text] [Related]

  • 8. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
    Stevens SR, Baron ED, Masten S, Cooper KD.
    Arch Dermatol; 2002 Oct 20; 138(10):1347-50. PubMed ID: 12374541
    [Abstract] [Full Text] [Related]

  • 9. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ.
    Clin Exp Dermatol; 2006 Mar 20; 31(2):181-6. PubMed ID: 16487086
    [Abstract] [Full Text] [Related]

  • 10. Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T-cell lymphoma.
    Aires D, Abhyankar S.
    Hematol Oncol; 2023 Dec 20; 41(5):809-816. PubMed ID: 37974524
    [Abstract] [Full Text] [Related]

  • 11. Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides.
    Lewis DJ, Duvic M.
    Dermatol Ther; 2017 May 20; 30(3):. PubMed ID: 28338261
    [Abstract] [Full Text] [Related]

  • 12. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
    Prinz B, Behrens W, Hölzle E, Plewig G.
    Arch Dermatol Res; 1995 May 20; 287(7):621-6. PubMed ID: 8534123
    [Abstract] [Full Text] [Related]

  • 13. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
    Quaglino P, Fierro MT, Rossotto GL, Savoia P, Bernengo MG.
    Br J Dermatol; 2004 Feb 20; 150(2):327-36. PubMed ID: 14996105
    [Abstract] [Full Text] [Related]

  • 14. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma.
    Seremet S, Abhyankar S, Herd TJ, Aires D.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1212-1216. PubMed ID: 27741338
    [Abstract] [Full Text] [Related]

  • 15. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.
    Quaglino P, Knobler R, Fierro MT, Savoia P, Marra E, Fava P, Bernengo MG.
    Int J Dermatol; 2013 Nov 01; 52(11):1308-18. PubMed ID: 23786842
    [Abstract] [Full Text] [Related]

  • 16. The treatment of cutaneous T-cell lymphoma with photopheresis.
    Zic JA.
    Dermatol Ther; 2003 Nov 01; 16(4):337-46. PubMed ID: 14686977
    [Abstract] [Full Text] [Related]

  • 17. Racial differences in the use of extracorporeal photopheresis for mycosis fungoides.
    Agi C, Kuhn D, Chung J, Zampella J, Hinds G.
    J Dermatolog Treat; 2015 Jun 01; 26(3):266-8. PubMed ID: 25034002
    [Abstract] [Full Text] [Related]

  • 18. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
    Gottlieb SL, Wolfe JT, Fox FE, DeNardo BJ, Macey WH, Bromley PG, Lessin SR, Rook AH.
    J Am Acad Dermatol; 1996 Dec 01; 35(6):946-57. PubMed ID: 8959954
    [Abstract] [Full Text] [Related]

  • 19. CD209+ monocyte-derived myeloid dendritic cells were increased in patients with leukemic cutaneous T-cell lymphoma undergoing extracorporeal photopheresis via the CELLEXTM system.
    Ni X, Austin M, Langridge T, Bojaxhi P, Bijani P, Wang X, Duvic M.
    Photodermatol Photoimmunol Photomed; 2020 Jul 01; 36(4):290-298. PubMed ID: 32187738
    [Abstract] [Full Text] [Related]

  • 20. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
    Crovetti G, Carabelli A, Berti E, Guizzardi M, Fossati S, De Filippo C, Bertani E.
    Int J Artif Organs; 2000 Jan 01; 23(1):55-62. PubMed ID: 12118838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.